A novel apoptosis gene identified in the pituitary gland

Neuroendocrinology

Volumn 84, Issue 4, 2007, Pages 217-221

  Farrell, W E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; Epigenetics; Pituitary adenomas; Pituitary tumour apoptosis gene (PTAG)

Indexed keywords

BROMOCRIPTINE; CASPASE; DNA FRAGMENT; PITUITARY TUMOUR APOPTOSIS PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVATION; GENE ASSIGNMENT; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; GENE MUTATION; GENE SILENCING; HUMAN; HYPOPHYSIS; HYPOPHYSIS TUMOR; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CPG ISLANDS; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; METHYLATION; NEOPLASM PROTEINS; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 33847788453     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097486     Document Type: Review

References (15)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
2. Asa SL, Ezzat S: The pathogenesis of pituitary tumors. Nat Rev Cancer 2002;2:836-849.
3. Melmed S: Mechanisms of pituitary tumorigenesis: the plastic pituitary. J Clin Invest 2003;112:1603-1618.
4. Zou H, McGarry TJ, Bernal T, Kirschner MW: Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999;285:418-422.
5. Farrell WE: Pituitary tumours: findings from whole genome analyses. Endocr Relat Cancer 2006;1:707-716.
6. Farrell WE: Epigenetic mechanisms of tumorigenesis. Horm Metab Res 2005;37:361-368.
7. Woloschak M, Yu A, Post KD: Frequent inactivation of the p16 gene in human pituitary tumours by gene methylation. Mol Carcinog 1997;19:221-224.
8. Simpson DJ, Bicknell JE, McNicol AM, Clayton RN, Farrell WE: Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with non-functional pituitary adenomas but not somatotrophinomas. Genes Chromosomes Cancer 1999;24:328-336.
9. Frost SJ, Simpson DJ, Clayton RN, Farrell WE: Transfection of an inducible p16/CDKN2A construct mediated reversible growth inhibition and G1 arrest in the AtT20 pituitary tumor cell line. Mol Endocrinol 1999;13:1801-1810.
10. Gonzalgo ML, Liang G, Spruck CH, Zingg JM, Rideout WH, Jones PA: Identification and characterisation of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 1997;57:594-599.
11. Bahar A, Simpson DJ, Cutty SJ, Bicknell JE, Hoban PR, Holley S, Mourtada-Maarabouni M, Williams GT, Clayton RN, Farrell WE: Isolation and characterization of a novel pituitary tumor apoptosis gene. Mol Endocrinol 2004;18:1827-1839.
12. Yin D, Kondo S, Takeuchi J, Morimura T, Vaux DL: Bcl-2 gene prevents apoptosis in murine ACTH-secreting adenoma cells induced by bromocriptine. Int J Oncol 1994;4:187-191.
13. Yin D, Tamaki N, Kokunai T, Yasuo K, Yonezawa K: Bromocriptine-induced apoptosis in pituitary adenoma cells: relationship to p53 and bcl-2 expression. J Clin Neurosci 1999;6:326-331.
14. Donanglo I, Melmed S: Treatment of acromegaly: future. Endocrine 2005;28:123-128.
15. Heaney AP, Fernando M, Yong WH, Melmed S: Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nat Med 2002;8:1281-1287.